M20-638Clinical Study Agreement • February 2nd, 2023
Contract Type FiledFebruary 2nd, 2023CLINICAL STUDY AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ AbbVie s.r.o., Karadžičova 10, 821 08 Bratislava, Slovak Republic, RN: 46640231, RN for tax: 2023529057, RN for VAT: SK2023529057, Legal Representative:, Company is registered in Trade Register of District Court Bratislava I. Part Sro, insertion no. 81375/B, ("AbbVie") is entering into agreement with Národný onkologický ústav, Klenová 1, 833 10 Bratislava, Slovak Republic, RN: 00165336, RN for tax: 2020830108, RN for VAT: SK2020830108, represented by:, Director (the “Institution”) and, Národný onkologický ústav, Physician of Oncohaematology Clinic, Klenová 1, 833 10 Bratislava, Slovak Republic (“Principal Investigator”) to conduct a clinical study (the “Study”) in relation to ABBV-GMAB-3013 (the “Study Product”) valid as of the date this Clinical Study Agreement (this “Agreement”) is fully executed, and effective as of the date following the day of this Agreement’s publication in accordance with applicable Slovak law, as stated below